Regenesis
Regenesis Biomedical is a Scottsdale, Arizona-based medical device manufacturer that produces the Reprieve line of FDA-cleared electromagnetic shortwave diathermy devices for non-drug, at-home pain relief, distributing them to U.S. veterans at no cost via Veterans Administration federal procurement and expanding into Native Community programs.
- Company typePrivate
- Founded1997
- HeadquartersScottsdale, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Regenesis does
Regenesis Biomedical, Inc., founded in 1997 and headquartered in Scottsdale, Arizona, is a privately held medical device manufacturer focused on non-drug pain relief. Its core product line is the Reprieve family of electromagnetic shortwave diathermy devices, which expose tissue to electromagnetic energy intended to produce an analgesic effect. The portfolio includes the base Reprieve unit plus variants (Reprieve-60, Reprieve-60 Duo, Reprieve Duo) configured with single or dual treatment pads, alongside supporting instructional materials such as pad positioning guides and instruction manuals. The devices are FDA-cleared and approved for home use, enabling patient self-treatment with twice-daily sessions and no required disposables.
The company's commercial model is anchored in federal healthcare procurement rather than direct-to-consumer sales. Reprieve is provided at no cost to eligible Veterans Administration (VA) health care beneficiaries, with revenue originating from government procurement — including distribution through the GSA Advantage marketplace under contract 36F79725D0002 — and supported by dedicated Patient Care Coordinators providing VA-centric treatment support. The company reports clinical adoption metrics of 30,000+ patients treated, 24,000+ veterans treated through the VA, 5+ million treatments delivered, and a 95% patient satisfaction rate, with targeted indications including diabetic neuropathy, plantar fasciitis, lumbar back pain, and osteoarthritis. Regenesis is also expanding beyond the VA through a specialized Pain Relief for Native Communities program.
The company is privately held with 101–250 employees, operates a single-country (USA) geographic footprint, and earns the U.S. Department of Labor HIRE Vets Gold Award in 2025 for veteran-focused hiring practices. Marketing is executed primarily through organic social channels (Facebook, LinkedIn, YouTube) for top-of-funnel awareness. No parent company, institutional investors, funding rounds, or material M&A activity are disclosed in the available data.
Regenesis firmographics
Firmographics- Name
- Regenesis
- Legal name
- Regenesis Biomedical Inc.
- Website
- https://regenesismed.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Regenesis Biomedical is a Scottsdale, Arizona-based medical device manufacturer that produces the Reprieve line of FDA-cleared electromagnetic shortwave diathermy devices for non-drug, at-home pain relief, distributing them to U.S. veterans at no cost via Veterans Administration federal procurement and expanding into Native Community programs.
- Ownership category
- akta.pro rank
Regenesis industry classification
Industry- Product category
- Pain Management Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Chronic Pain Rehabilitation & Functional Restoration (HSADAIAJ)
Keywords
Where Regenesis is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Regenesis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Medical Device Distribution to VA Healthcare: Reprieve devices are provided at no cost to Veterans Administration health care beneficiaries, suggesting a model where the company supplies devices to VA healthcare facilities at no cost to patients. Revenue appears to come from government healthcare system procurement rather than direct patient sales.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | VA Healthcare Program - No cost to eligible Veterans |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Regenesis product offering
Product offeringCore offering
Regenesis manufactures and distributes the Reprieve line of electromagnetic shortwave diathermy medical devices for non-drug pain relief. Devices are FDA-cleared for home use, enabling patients to self-treat chronic pain conditions (diabetic neuropathy, plantar fasciitis, back pain, osteoarthritis) through twice-daily electromagnetic therapy sessions. The primary distribution channel is the Veterans Administration healthcare system, where Reprieve devices are provided at no cost to eligible VA health care beneficiaries.
Product overview
Regenesis offers a focused portfolio of medical devices centered on its Reprieve line of electromagnetic shortwave diathermy therapy products. The core Reprieve device and its variants (Reprieve-60, Reprieve-60 Duo, Reprieve Duo) deliver non-drug pain management for home use. The company primarily serves the Veterans Administration healthcare system, providing devices at no cost to eligible veterans. Treatment protocols target common pain conditions including diabetic neuropathy, plantar fasciitis, lumbar back pain, and osteoarthritis, with supporting instructional materials including pad positioning guides and user manuals.
Differentiator
Problem solved
Functional benefit
Brands
- Reprieve: Shortwave diathermy medical device for safe, non-drug pain relief. Patients can self-treat at home. Available at no cost to Veterans Administration (VA) health care beneficiaries.
Products and services
- Reprieve by Regenesis
- Reprieve-60 Shortwave diathermy device model variant with standard energy settings based on research, intended to provide an analgesic effect for non-drug pain relief.
- Reprieve-60 Duo Dual-pad shortwave diathermy device model for expanded treatment coverage and broader tissue treatment area.
- Reprieve Duo Dual treatment pad configuration shortwave diathermy device providing broader tissue treatment area for non-drug pain relief.
Quantifiable outcome
- Over 30,000 patients treated with proven clinical outcomes
- +2 more outcomes
Companies that use Regenesis
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Regenesis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Regenesis partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Regenesis competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Regenesis social profiles
Digital presenceRegenesis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Regenesis leadership team
Management profileNumber of profiles
Regenesis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Regenesis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Regenesis
What does Regenesis do?
Regenesis manufactures and distributes the Reprieve line of electromagnetic shortwave diathermy medical devices for non-drug pain relief. Devices are FDA-cleared for home use, enabling patients to self-treat chronic pain conditions (diabetic neuropathy, plantar fasciitis, back pain, osteoarthritis) through twice-daily electromagnetic therapy sessions. The primary distribution channel is the Veterans Administration healthcare system, where Reprieve devices are provided at no cost to eligible VA health care beneficiaries.
Is Regenesis a public or private company?
Regenesis is a private company. It is classified as unknown and is currently operating.
When was Regenesis founded?
Regenesis was founded in 1997. It employs 101 to 250 people.
Where is Regenesis based?
Regenesis is headquartered in Scottsdale, United States, in the North America region.
How does Regenesis make money?
One revenue line is on record: medical Device Distribution to VA Healthcare.
Does Regenesis have an API?
No public API is recorded for Regenesis.
What industry is Regenesis in?
Regenesis's product category is Pain Management Medical Devices. Its primary akta.pro industry code is HSADAIAJ, Chronic Pain Rehabilitation & Functional Restoration. Its NAICS code is 334510 and its SIC code is 3845.